New Key Statistics Module, Z-Score and F-Score
OTCPK:SBMFF Key Ratios
Market Cap $ M | 7,335.81 |
Enterprise Value $ M | 7,120.61 |
P/E(ttm) | 13.08 |
PE Ratio without NRI | 24.72 |
Forward PE Ratio | 18.17 |
Price/Book | 1.73 |
Price/Sales | 2.00 |
Price/Free Cash Flow | 12.22 |
Price/Owner Earnings | 34.89 |
Payout Ratio % | 0.44 |
Revenue (TTM) $ M | 3,717.00 |
EPS (TTM) $ | 0.03 |
Beneish M-Score | -2.73 |
10-y EBITDA Growth Rate % | 12.80 |
5-y EBITDA Growth Rate % | -6.80 |
y-y EBITDA Growth Rate % | 4.60 |
EV-to-EBIT | 8.34 |
EV-to-EBITDA | 8.34 |
PEG | -- |
Shares Outstanding M | 18,215.47 |
Net Margin (%) | 15.23 |
Operating Margin % | 22.12 |
Pre-tax Margin (%) | 21.63 |
Quick Ratio | 0.96 |
Current Ratio | 1.05 |
ROA % (ttm) | 6.23 |
ROE % (ttm) | 13.35 |
ROIC % (ttm) | 9.17 |
Dividend Yield % | 1.68 |
Altman Z-Score | 2.50 |
SBMFF Number of Guru Trades
SBMFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SBMFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SBMFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sino Biopharmaceutical Ltd Insider Transactions
No Available Data
News about OTCPK:SBMFF
Total 0- 1